Suppr超能文献

儿科肥胖代谢易感性评估(POEMS)。

Paediatric Obesity Evaluation for Metabolic Susceptibility (POEMS).

机构信息

Endocrinology Service, KK Women's and Children's Hospital, Singapore

Paediatric Medicine, KK Women's and Children's Hospital, Singapore.

出版信息

BMJ Open Diabetes Res Care. 2023 Apr;11(2). doi: 10.1136/bmjdrc-2022-003228.

Abstract

INTRODUCTION

Our aim was to determine whether there are risk factors which increase the risk of developing dysglycemia in a child who has increased body mass index (BMI) (overweight/obese).

RESEARCH DESIGN AND METHODS

This was a retrospective cohort study of 715 children who had increased BMI (overweight/obese). They presented to tertiary care at KK Women's and Children's Hospital, Singapore, for metabolic risk assessment. Subjects who had more than one oral glucose tolerance test were included in order to track and analyze risk factors associated with worsening glycemic status from a previously normal glucose tolerance, impaired fasting glucose, or impaired glucose tolerance (IGT) state. Demographic characteristics, birth history, family history of metabolic syndrome, metabolic comorbidities, and interventions received were recorded. Statistical analysis was performed to determine odds ratio (OR) of worsening glycemic status progression in association with an analyzed variable, adjusted for intervention received.

RESULTS

Risk factors of developing dysglycemia can be present right from birth, as participants who were born preterm had increased odds of IGT (OR: 3.49 (1.10 to 11.03)), and a greater proportion of large-for-gestational-age (LGA)/small-for-gestational-age (SGA) babies had dysglycemia (SGA-IGT: 8.8%, SGA-diabetes mellitus (DM): 5.9%, LGA-IGT: 10.6%, LGA-DM: 11.8%) even at baseline. Being born preterm (OR: 3.49 (1.10 to 11.03)), with comorbidities of hypertension (OR: 1.61 (1.01 to 2.57)), hyperlipidemia (OR: 1.80 (1.19 to 2.72)), and fatty liver disease (OR: 2.08 (1.39 to 3.13)), was significantly associated with an increased OR of developing IGT. Risk factors for developing a worsening glycemic status, either to IGT or DM, included age >10 years (OR 4.94 (1.21 to 20.25)), BMI rise (OR 1.71 (1.17 to 2.49)), BMI increase >1.08 kg/m (OR 1.71 (1.16 to 2.51)), comorbidities of hyperlipidemia (OR 1.67 (1.12 to 2.50)), and fatty liver disease (OR 2.11 (1.43 to 3.12)).

CONCLUSIONS

A child who has increased BMI (overweight/obese) and possesses risk factors for worsening glycemic status, if intervened with routine lifestyle modification advice, may still have increased risk of developing dysglycemia and type 2 DM. Therefore, understanding their risk profile provides opportunities to have a tiered and individualized approach.

摘要

简介

我们的目的是确定在 BMI(超重/肥胖)增加的儿童中,是否存在增加发生糖代谢异常风险的危险因素。

研究设计与方法

这是一项对 715 名 BMI 增加(超重/肥胖)的儿童进行的回顾性队列研究。他们在新加坡 KK 妇女儿童医院接受了代谢风险评估。为了追踪和分析从先前正常葡萄糖耐量、空腹血糖受损或糖耐量受损(IGT)状态恶化的与血糖相关的危险因素,纳入了有多次口服葡萄糖耐量试验的患者。记录了人口统计学特征、出生史、代谢综合征家族史、代谢合并症和接受的干预措施。为了确定与分析变量相关的血糖恶化进展的优势比(OR),对接受的干预措施进行了调整,并进行了统计分析。

结果

发生糖代谢异常的危险因素可能从出生时就存在,因为早产儿发生 IGT 的几率更高(OR:3.49(1.10 至 11.03)),并且比例较大的大于胎龄儿(LGA)/小于胎龄儿(SGA)婴儿有糖代谢异常(SGA-IGT:8.8%,SGA-糖尿病:5.9%,LGA-IGT:10.6%,LGA-糖尿病:11.8%)即使在基线时也是如此。早产(OR:3.49(1.10 至 11.03))、合并高血压(OR:1.61(1.01 至 2.57))、血脂异常(OR:1.80(1.19 至 2.72))和脂肪肝疾病(OR:2.08(1.39 至 3.13))是发生 IGT 的 OR 显著增加的危险因素。发生血糖恶化(IGT 或糖尿病)的危险因素包括年龄>10 岁(OR 4.94(1.21 至 20.25))、BMI 升高(OR 1.71(1.17 至 2.49))、BMI 增加>1.08 kg/m(OR 1.71(1.16 至 2.51))、血脂异常(OR 1.67(1.12 至 2.50))和脂肪肝疾病(OR 2.11(1.43 至 3.12))。

结论

BMI 增加(超重/肥胖)且存在血糖恶化风险因素的儿童,如果接受常规生活方式改变建议的干预,仍可能有发生糖代谢异常和 2 型糖尿病的风险增加。因此,了解他们的风险状况提供了分层和个体化的机会。

相似文献

1
Paediatric Obesity Evaluation for Metabolic Susceptibility (POEMS).
BMJ Open Diabetes Res Care. 2023 Apr;11(2). doi: 10.1136/bmjdrc-2022-003228.
2
Predicting adult metabolic syndrome from childhood body mass index: follow-up of the New Delhi birth cohort.
Arch Dis Child. 2009 Oct;94(10):768-74. doi: 10.1136/adc.2008.140905. Epub 2008 Nov 17.
5
Prevalence of type 2 diabetes mellitus, metabolic syndrome, and related morbidities in overweight and obese children.
J Pediatr Endocrinol Metab. 2022 Jan 17;35(4):435-441. doi: 10.1515/jpem-2021-0271. Print 2022 Apr 26.
8
Dysglycemia and long-term mortality: observations from the Israel study of glucose intolerance, obesity and hypertension.
Diabetes Metab Res Rev. 2015 May;31(4):368-75. doi: 10.1002/dmrr.2618. Epub 2014 Dec 12.

本文引用的文献

2
Long-Term Complications in Youth-Onset Type 2 Diabetes. Reply.
N Engl J Med. 2021 Nov 18;385(21):2016. doi: 10.1056/NEJMc2114053.
3
Are people with metabolically healthy obesity really healthy? A prospective cohort study of 381,363 UK Biobank participants.
Diabetologia. 2021 Sep;64(9):1963-1972. doi: 10.1007/s00125-021-05484-6. Epub 2021 Jun 10.
4
Long-term cardiometabolic disease risk in women with PCOS: a systematic review and meta-analysis.
Hum Reprod Update. 2020 Nov 1;26(6):942-960. doi: 10.1093/humupd/dmaa029.
5
Nutritional Gaps and Supplementation in the First 1000 Days.
Nutrients. 2019 Nov 27;11(12):2891. doi: 10.3390/nu11122891.
6
Recent Insights Into Mechanisms of β-Cell Lipo- and Glucolipotoxicity in Type 2 Diabetes.
J Mol Biol. 2020 Mar 6;432(5):1514-1534. doi: 10.1016/j.jmb.2019.09.016. Epub 2019 Oct 16.
7
Sex hormone-binding globulin and polycystic ovary syndrome.
Clin Chim Acta. 2019 Dec;499:142-148. doi: 10.1016/j.cca.2019.09.010. Epub 2019 Sep 13.
8
Understanding the mechanisms of reversal of type 2 diabetes.
Lancet Diabetes Endocrinol. 2019 Sep;7(9):726-736. doi: 10.1016/S2213-8587(19)30076-2. Epub 2019 May 13.
9
THE ASSOCIATION BETWEEN FIRST-DEGREE FAMILY HISTORY OF DIABETES AND METABOLIC SYNDROME.
Endocr Pract. 2019 Jul;25(7):678-683. doi: 10.4158/EP-2018-0543. Epub 2019 Mar 13.
10
2. Classification and Diagnosis of Diabetes: .
Diabetes Care. 2019 Jan;42(Suppl 1):S13-S28. doi: 10.2337/dc19-S002.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验